Exosome Metabolomics Service
Metabolomics analysis of exosomes is a new field of research which could reveal potential biomarkers for various diseases. Studies on the metabolomics exhibit the changes in exosome metabolite profiles associated with diseases.
A recent study showed the changes in the metabolite profiles of extracellular vesicles (EVs) from prostate cancer (Pca) patients before and after prostatectomy, suggesting that EV metabolomics may provide a new non-invasive and high-throughput tool to monitor Pca or other diseases.
Figure 1 Most significant changes in the urinary EV metabolites in prostate cancer.
Figure 2 Comparison of the metabolite contents in the EVs and their source materials.
Staffed with well-experienced experts in the field, Creative Bioarray provides:
- Isolation and Validation of Exosome Samples
- Metabolomics Analysis
- Raw MS Spectra Data
- Data Analysis
- A Full Technical Report
If you request a quote for exosome metabolomics service or request additional information, please contact us. We look forward to working with you in the future.
Reference
- Puhka, M.; et al. Metabolomic profiling of extracellular vesicles and alternative normalization methods reveal enriched metabolites and strategies to study prostate cancer-related changes. Theranostics. 2017, 7(16): 3824-3841.
Explore Other Options
For research use only. Not for any other purpose.
Services
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
Molecular Biology Solutions
- Chromosome & Genomic Analysis
-
Cytogenetics & Molecular Cytogenetics Analysis
- Fluorescent In Situ Hybridization (FISH)
- In Situ Hybridization (ISH) & RNAscope
- ImmunoFISH (FISH+IHC)
- I-FISH
- Splice Variant Analysis (FISH)
- RNA FISH in Plant
- mtRNA Analysis (FISH)
- Digital ISH Image Quantification and Statistical Analysis
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- Droplet Digital PCR (ddPCR)
- QuantiGene Plex Assay
- Probe Development & Quality Control
- ISH/FISH Analysis for Therapeutic R&D
- Cell Line Characterization
- Pathogen & Microbial Analysis
- Histology Services
- Exosome Research Services
- Drug Metabolism and Pharmacokinetics (DMPK)
-
Safety Evaluation Services
- High-Throughput Toxicity Screening
- High-Content Cytotoxicity Screening
- In Vitro Cardiotoxicity
- In Vitro Genotoxicity
- Hepatotoxicity
- In Vitro Neurotoxicity
- In Vitro Nephrotoxicity
- In Vitro Dermal Toxicology
- Ocular Toxicity
- In Vitro Cytotoxicity
- Endocrine Disruption Screening Assay
- In Vivo Toxicity Study